Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA bendamustine CTRPv2 pan-cancer AAC -0.016 0.7
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.033 0.7
mRNA TKI258 CCLE pan-cancer AAC -0.02 0.7
mRNA myriocin CTRPv2 pan-cancer AAC -0.033 0.7
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA Erlotinib FIMM pan-cancer AAC -0.067 0.7
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.013 0.7
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA Tipifarnib FIMM pan-cancer AAC 0.05 0.7
Download CSV